Evidence map›Paper›PMID 42477406›Full record

ArticleEuropean journal of human genetics : EJHG2026

Genome-wide assessment of rare protein-coding variants identifies associations with non-syndromic cleft lip/palate.

Yao Yu, Gabriel J Kowalczyk, Chad D Huff, Jacqueline T Hecht, Ariadne Letra

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of human genetics : EJHG, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yao YuDepartment of Epidemiology, UT MD Anderson Cancer Center, Houston, TX, USA.
Gabriel J KowalczykDepartment of Oral and Craniofacial Sciences, University of Pittsburgh School of Dental Medicine, Pittsburgh, PA, USA.ORCID http://orcid.org/0009-0009-7454-9307
Chad D Huff *Department of Epidemiology, UT MD Anderson Cancer Center, Houston, TX, USA.
Jacqueline T Hecht *Department of Pediatrics, UTHealth McGovern Medical School, Houston, TX, USA.
Ariadne Letra *Department of Oral and Craniofacial Sciences, University of Pittsburgh School of Dental Medicine, Pittsburgh, PA, USA. AriadneLetra@pitt.edu.ORCID http://orcid.org/0000-0002-7197-6735

Funding

MOLECULAR STUDIES IN NONSYNDROMIC CLEFT LIP AND PALATER01DE011931 · NIDCR · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI BLANTON, SUSAN HALLORAN, HECHT, JACQUELINE T · 1999 to 2017
$7.6M
Leveraging novel methods to improve nonsyndromic cleft lip/palate gene discoveryR03DE032160 · NIDCR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HECHT, JACQUELINE T, LETRA, ARIADNE M · 2022 to 2023
$351k
U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research (NIDCR) R01DE011931U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research (NIDCR) R03DE032160U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research (NIDCR) X01DE031445-01
6 · The paper itself

Abstract

Nonsyndromic cleft lip and palate (NSCLP) is a complex, multifactorial condition for which only about 25% of the genetic contribution has been identified. Although more than 60 genetic loci have been associated with NSCLP, a large portion of its heritability remains unexplained. Rare variants-often with stronger functional effects-are believed to account for some of this missing genetic risk. In this study, short-read whole-genome sequencing data from 786 NSCLP cases and 2149 controls were analyzed to identify genes enriched for rare protein-coding variants. Gene-based association testing, meta-analysis, functional prioritization, and effect-size estimation revealed several novel NSCLP candidate genes and confirmed associations with previously reported genes. The four novel candidate genes with the strongest association evidence were SCT, MALRD1, GPR156, and MYOCOS, all with p-values < 10⁻⁴. Replication of known genes was most robust for ARHGAP29, FGF8, SKI, and TP63. Pathway analyses showed significant enrichment of these genes in neuroactive ligand-receptor interactions, MAPK signaling, and other signal transduction pathways. Precise estimates of the risks conferred by the identified rare variants showed a substantial increase in NSCLP risk, with odds ratio point estimates between 2 and 4. These results provide strong support for a polygenic inheritance model in NSCLP, in which certain genes contribute varying levels of risk.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.